0001838780-22-000001.txt : 20220504 0001838780-22-000001.hdr.sgml : 20220504 20220504085634 ACCESSION NUMBER: 0001838780-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: 4a5 FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220504 EFFECTIVENESS DATE: 20220504 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hemispherian AS CENTRAL INDEX KEY: 0001838780 IRS NUMBER: 000000000 STATE OF INCORPORATION: Q8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-444332 FILM NUMBER: 22889961 BUSINESS ADDRESS: STREET 1: GAUSTADALLEEN 21 CITY: OSLO STATE: Q8 ZIP: 0349 BUSINESS PHONE: 4746390867 MAIL ADDRESS: STREET 1: GAUSTADALLEEN 21 CITY: OSLO STATE: Q8 ZIP: 0349 D 1 primary_doc.xml X0708 D LIVE 0001838780 Hemispherian AS GAUSTADALLEEN 21 OSLO Q8 NORWAY 0349 4746390867 NORWAY None None Corporation true 2020 Zeno Albisser Teglverksgata 7A Oslo Q8 NORWAY 0553 Executive Officer Dallas Christian Hack 3065 Federal Blvd Morristown TN TENNESSEE 32714 Director Masha Paule Nathalie Legris Stromme Tuengen Alle 4 Oslo Q8 NORWAY 0374 Director Cecilie Stenstadvold Sverdrup Staviveien 33 Voyenenga Q8 NORWAY 1339 Director Steven John Powell Clunch Cottage Hillfoot Cocking X0 UNITED KINGDOM GU29 OHR Director Adam Brian Robertson Avstikkeren 9 Oslo Q8 NORWAY 1156 Promoter Co-Founder, Chief Science Officer Terezia Prikrylova Jens Bjelkes gate 82F Oslo Q8 NORWAY 0652 Promoter Co-Founder, Chief Operating Officer Pharmaceuticals $1 - $1,000,000 06c 4a5 false 2022-04-27 false true false 10000 50000 50000 0 Internationally, the total offering was NOK 12,500,000 (about USD 1,331,856). However, only shares with a total value of USD 50,000 were offered to two specific investors in the US. These investors also contributed in our previous financing round. false 2 0 0 No commissions or finders' fees are paid. 10000 true The proceeds will be matched by Norwegian grant funding and international investors to fund pre-clinical pharmaceutical development, including salaries for employees. false Hemispherian AS Zeno Albisser Zeno Albisser CEO 2022-05-04